Related Experiment Video
Updated: Feb 21, 2026

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Conservative management of primary vaginal endodermal sinus tumor and rhabdomyosarcoma
Weimin Xie1, Keng Shen1, Jiaxin Yang1
1Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Insights
Conservative management for pediatric vaginal endodermal sinus tumors and rhabdomyosarcomas shows promising outcomes. Early treatment strategies aim to preserve sexual and reproductive function in young patients.
Area of Science:
- Pediatric Oncology
- Gynecologic Oncology
- Rare Pediatric Cancers
Background:
- Primary vaginal tumors in children are rare, with endodermal sinus tumors and rhabdomyosarcomas being the most common types.
- Management strategies require careful consideration to balance oncologic control with long-term functional outcomes.
Purpose of the Study:
- To evaluate the efficacy of conservative management and the prognosis of primary vaginal endodermal sinus tumors and rhabdomyosarcomas in pediatric patients.
- To assess the feasibility of fertility-sparing treatment approaches for these rare gynecologic malignancies.
Main Methods:
- Retrospective review of medical records for pediatric patients diagnosed with vaginal endodermal sinus tumor or rhabdomyosarcoma between 1996 and 2015.
- Analysis of treatment modalities, including chemotherapy and conservative surgical approaches, and patient outcomes, including recurrence and survival rates.
Main Results:
- A total of 24 patients (median age 12 months) were included: 17 with endodermal sinus tumor and 7 with rhabdomyosarcoma.
- The majority of endodermal sinus tumor patients received chemotherapy alone, while rhabdomyosarcoma patients received chemotherapy without standardized protocols.
- Overall, 91.7% of patients survived without evidence of disease at last follow-up, with a low recurrence rate of 12.5%.
Conclusions:
- Conservative therapeutic strategies, including chemotherapy and judicious surgical intervention, should be prioritized for pediatric vaginal endodermal sinus tumors and botryoid rhabdomyosarcomas.
- These approaches can achieve high survival rates while preserving sexual and reproductive function.
- Further research into standardized, fertility-sparing protocols is warranted for these rare pediatric malignancies.
Abstract:
The aim of this study was to evaluate the conservative management and prognosis of primary vaginal endodermal sinus tumor and rhabdomyosarcoma in children. Medical records of children with vaginal endodermal sinus tumor and rhabdomyosarcoma between 1996 and 2015 were reviewed. A total of 24 patients (median age, 12 months; range, 7-44 months) were included in this study, comprising 17 patients with endodermal sinus tumor and 7 patients with rhabdomyosarcoma. Among the 17 patients with endodermal sinus tumor, 15 were initially treated at our hospital with chemotherapy alone, and 2 were initially treated in other hospitals with conservative surgery and chemotherapy. All 7 patients with botryoid rhabdomyosarcoma received chemotherapy without well-defined protocols. At a median follow-up of 51 months (range, 4-237 months), 3 patients (12.5%; 1 with endodermal sinus tumor and 2 with rhabdomyosarcoma) developed recurrence. At the last follow-up, 22 patients (91.7%) were alive without evidence of disease, 1 patient with botryoid rhabdomyosarcoma died of disease progression, and 1 patient with endodermal sinus tumor died of respiratory and circulatory failure. To allow preservation of sexual and reproductive function, conservative therapeutic strategies should be considered for children with vaginal endodermal sinus tumor and botryoid rhabdomyosarcoma.

